We are live on
!
Find out more
Oric Pharmaceuticals
ORIC
ORIC
129 hedge funds and large institutions have $612M invested in Oric Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 51 increasing their positions, 26 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
6,175% more call options, than puts
Call options by funds: $3.26M | Put options by funds: $52K
96% more repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 26
35% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 20
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
8.42% more ownership
Funds ownership: 98.98% → 107.4% (+8.4%)
6% more funds holding
Funds holding: 122 → 129 (+7)
14% less capital invested
Capital invested by funds: $715M → $612M (-$103M)
Holders
129
Holders Change
+7
Holders Change %
+5.74%
% of All Funds
1.7%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.07%
New
27
Increased
51
Reduced
26
Closed
20
Calls
$3.26M
Puts
$52K
Net Calls
+$3.21M
Net Calls Change
+$3.06M
Top Buyers
| 1 |
SSA
Schonfeld Strategic Advisors
New York
|
+$6.65M |
| 2 |
SCM
Superstring Capital Management
New York
|
+$5.79M |
| 3 |
Viking Global Investors
Stamford,
Connecticut
|
+$3.95M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$3.89M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$1.65M |
